DIN 02382482 — NALOXONE HYDROCHLORIDE INJECTION USP 0.4 MG
NALOXONE HYDROCHLORIDE INJECTION USP is a solution of Naloxone marketed by HIKMA CANADA LIMITED. The full Naloxone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02382482
- Brand name
- NALOXONE HYDROCHLORIDE INJECTION USP
- Active ingredient
- Naloxone
- Strength
- 0.4 MG
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Manufacturer
- HIKMA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Opioid antagonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Naloxone products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02455935 | INJECTABLE NALOXONE HYDROCHLORIDE | 0.4 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED |
| 02148706 | NALOXONE HCL INJECTION - 0.4MG/ML USP | 0.4 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED |
| 02148714 | NALOXONE HCL INJECTION - 1MG/ML USP | 1 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED |
| 02393034 | NALOXONE HYDROCHLORIDE INJECTION | 0.4 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED |
| 02393042 | NALOXONE HYDROCHLORIDE INJECTION | 1 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED |
| 02548194 | NALOXONE HYDROCHLORIDE INJECTION USP | 0.4 MG | SOLUTION | STERINOVA INC. | MARKETED |
| 02534975 | NALOXONE HYDROCHLORIDE INJECTION, USP | 4 MG | SOLUTION | EUGIA PHARMA INC. | MARKETED |
| 02458578 | NALOXONE INJECTABLE | 0.4 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED |
| 02458187 | NARCAN NASAL SPRAY | 4 MG | SPRAY (METERED-DOSE) | EMERGENT OPERATIONS IRELAND LIMITED | MARKETED |
| 02453258 | S.O.S. NALOXONE HYDROCHLORIDE INJECTION | 0.4 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02511568 | TEVA-NALOXONE NASAL SPRAY | 4 MG | SPRAY (METERED-DOSE) | TEVA CANADA LIMITED | MARKETED |